Cardiovascular Outcome Trials of Diabetes Drugs: Lessons Learned

Journal of Clinical Investigation- United States

doi 10.1172/jci99820

Full Text

Abstract

Available in

Categories

Medicine

Date

Authors

Publisher

American Society for Clinical Investigation

Related search

Cardiovascular Outcome Trials in Diabetes: What Have We Learnt?

Trends in Urology & Men's Health
2018English

Recent Lessons Learned From Prevention and Recent-Onset Type 1 Diabetes Immunotherapy Trials

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2012English

Lessons Learned From Two Decades of Anticancer Drugs

Trends in Pharmacological Sciences
ToxicologyPharmacology
2017English

Erratum. Mitigating Cardiovascular Risk in Type 2 Diabetes With Antidiabetes Drugs: A Review of Principal Cardiovascular Outcome Results of EMPA-REG OUTCOME, LEADER, and SUSTAIN-6 Trials. Diabetes Care 2017;40:821–831

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2018English

Lessons From a Cardiovascular Outcome Trial With Liraglutide in Type 2 Diabetes

Journal of Diabetes Investigation
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2017English

Managing Cardiovascular Risk in Type 2 Diabetes: What Do the Cardiovascular Outcome Trials Mean for Australian Practice?

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Lessons Learned From HIV-1 Vaccine Trials: New Priorities and Directions

Nature Immunology
AllergyImmunology
2013English

Lessons Learned

Advances in Social Work
2020English

Lessons Learned

2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy